U.S. FDA gives emergency use approval to GSK-Vir COVID-19 antibody drug

(Reuters) – The U.S. Food and Drug administration on Wednesday gave an emergency use authorization to the COVID-19 antibody treatment developed by Vir Biotechnology Inc and GlaxoSmithKline. (https://bit.ly/3uorQZ8)

(Reporting by Amruta Khandekar; Editing by Shounak Dasgupta)